EUCTR2009-016377-15-IT进行中（未招募）不适用
DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL TO TEST THE EFFICACY, SAFETY AND TOLERABILITY OF LITHIUM IN MULTIPLE SYSTEM ATROPHY - Lithium in MSA
IVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II0 个研究点开始时间: 2009年10月26日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Clinical diagnosis of probable MSA, age >18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Heart, liver or renal disease, thyroid dysfunction, treatment with not allowed drugs, acute disease that might interfere with the study, pregnancy and/or breastfeading
研究者
相似试验
进行中（未招募）
1 期
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 6 MONTHS VERSUS 12 MONTHS CLOPIDOGREL THERAPY AFTER IMPLANTATION OF A DRUG-ELUTING STENTPatients with established coronary artery disease on chronic clopidogrel therapy at 6 months after coronary drug eluting stent implantation.MedDRA version: 17.0Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2007-006263-68-DEDeutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen4,000
进行中（未招募）
1 期
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 6 MONTHS VERSUS 12 MONTHS CLOPIDOGREL THERAPY AFTER IMPLANTATION OF A DRUG-ELUTING STENT SAFETY AND EFFICACY OF SIX MONTHS DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING – ISAR-SAFE - ISAR-SAFEPatients with established coronary artery disease on chronic clopidogrel therapy at 6 months after coronary drug eluting stent implantation.MedDRA version: 14.0Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2007-006263-68-ATDeutsches Herzzentrum Muenchen6,000
进行中（未招募）
1 期
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF 6 MONTHS VERSUS 12 MONTHS CLOPIDOGREL THERAPY AFTER IMPLANTATION OF A DRUG-ELUTING STENT SAFETY AND EFFICACY OF SIX MONTHS DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING – ISAR-SAFE - ISAR-SAFEPatients with established coronary artery disease on chronic clopidogrel therapy at 6 months after coronary drug eluting stent implantation.MedDRA version: 14.1Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersEUCTR2007-006263-68-DKDeutsches Herzzentrum Muenchen6,000
进行中（未招募）
不适用
A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE TIME TO ONSET OF MEANINGFUL PAIN RELIEF IN SUBJECTS WITH POSTHERPETIC NEURALGIA (PHN) TREATED WITH PREGABALIN (150 - 600 MG/DAY FLEXIBLE OPTIMIZED DOSE OR 300 MG/DAY FIXED DOSE OR PLACEBOMedDRA version: 6.1Level: HLTClassification code 10034607Postherpetic NeuralgiaEUCTR2004-002563-24-ITPFIZER
尚未招募
不适用
Bridging Trial of Bivalent Killed Oral Cholera Vaccine in EthiopiaCholeraPACTR201202000354245International Vaccine Institute216